...
首页> 外文期刊>European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology >N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): Correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial
【24h】

N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): Correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial

机译:N端脑钠肽前体在急诊科(PROMPT)患者管理中的作用:与疾病严重性,医院资源的利用以及大型,前瞻性,随机,多中心试验的预后相关

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: N-terminal pro brain natriuretic peptide (NT-proBNP) is a potent marker of heart failure and other cardiac diseases. The value of NT-proBNP testing in the medical emergency department (ED) was assessed in patients >65 years old. Methods and results: This large, prospective, randomized, controlled, multicentre trial was conducted in six medical EDs. Data for evaluation of the primary endpoint of hospitalization were available for 1086 patients. Median NT-proBNP was 582 pg/mL. A total of 16% of patients presented with NT-proBNP <150 pg/mL (low), 55% with NT-proBNP between 150 and 1800 pg/mL (intermediate), and 29 with NT-proBNP >1800 pg/mL (high). NT-proBNP was positively correlated with hospital admission [odds ratio (OR) for high vs. low 2.9, P < 0.0001], length of stay (8.5 days vs. 3.5 days for high vs. low, P < 0.01), in-hospital death (3.9% vs. 0% for high vs. low, P < 0.01), 6 months re-hospitalization (OR for high vs. low 5.1, P < 0.0001), and 6 months death or re-hospitalization (OR for high vs. low 5.7, P < 0.0001). Knowledge of NT-proBNP had no significant effect on the primary endpoint hospital admission and the secondary endpoints intermediate/intensive care unit (IMC/ICU) admission, length of stay, re-hospitalization and death, or re-hospitalization in the total cohort. However, patients with high open NT-proBNP (>1800 pg/mL) were more likely to be admitted to the hospital (P < 0.05) and IMC/ICU (P < 0.05), whereas patients with low open NT-proBNP (<150 pg/mL) were less likely to be admitted (P < 0.05) compared with patients with blinded NT-proBNP. Conclusion: Although NT-proBNP does not affect overall hospitalization, it is associated with better stratification of patient care and is strongly correlated with subsequent utilization of hospital resources and prognosis.
机译:目的:N端脑钠素前体肽(NT-proBNP)是心力衰竭和其他心脏病的有效标志物。在65岁以上的患者中评估了急诊科(ED)中NT-proBNP检测的价值。方法和结果:这项大型,前瞻性,随机,对照,多中心试验在6个医学ED中进行。 1086例患者可获得用于评估住院主要终点指标的数据。 NT-proBNP的中位数为582 pg / mL。共有16%的患者出现NT-proBNP <150 pg / mL(低),55%的NT-proBNP在150至1800 pg / mL之间(中级)和29例NT-proBNP> 1800 pg / mL(高)。 NT-proBNP与住院率呈正相关[高/低2.9的比值比(OR),P <0.0001],住院时间(高与低8.5天vs. 3.5天,P <0.01),住院死亡(高危与低危分别为3.9%和0%,P <0.01),住院治疗6个月(高危与低血压分别为5.1,P <0.0001)和6个月死亡或重新住院(OR为高值与低值5.7,P <0.0001)。 NT-proBNP的知识对主要终点医院入院和次要终点中/重症监护病房(IMC / ICU)的入院,住院时间,重新住院和死亡或重新住院总人数均无显着影响。然而,高开放NT-proBNP(> 1800 pg / mL)的患者更有可能入院(P <0.05)和IMC / ICU(P <0.05),而低开放NT-proBNP(与盲NT-proBNP患者相比,150 pg / mL)的可能性较小(P <0.05)。结论:尽管NT-proBNP不会影响整体住院治疗,但它与更好的患者护理分层相关,并与随后的医院资源利用和预后密切相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号